Edwards Lifesciences Corp
NYSE:EW
US |
Fubotv Inc
NYSE:FUBO
|
Media
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
C
|
C3.ai Inc
NYSE:AI
|
Technology
|
US |
Uber Technologies Inc
NYSE:UBER
|
Road & Rail
|
|
CN |
NIO Inc
NYSE:NIO
|
Automobiles
|
|
US |
Fluor Corp
NYSE:FLR
|
Construction
|
|
US |
Jacobs Engineering Group Inc
NYSE:J
|
Professional Services
|
|
US |
TopBuild Corp
NYSE:BLD
|
Consumer products
|
|
US |
Abbott Laboratories
NYSE:ABT
|
Health Care
|
|
US |
Chevron Corp
NYSE:CVX
|
Energy
|
|
US |
Occidental Petroleum Corp
NYSE:OXY
|
Energy
|
|
US |
Matrix Service Co
NASDAQ:MTRX
|
Construction
|
|
US |
Automatic Data Processing Inc
NASDAQ:ADP
|
Technology
|
|
US |
Qualcomm Inc
NASDAQ:QCOM
|
Semiconductors
|
|
US |
Ambarella Inc
NASDAQ:AMBA
|
Semiconductors
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
59.7
95.56
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
Fubotv Inc
NYSE:FUBO
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
C
|
C3.ai Inc
NYSE:AI
|
US |
Uber Technologies Inc
NYSE:UBER
|
US | |
NIO Inc
NYSE:NIO
|
CN | |
Fluor Corp
NYSE:FLR
|
US | |
Jacobs Engineering Group Inc
NYSE:J
|
US | |
TopBuild Corp
NYSE:BLD
|
US | |
Abbott Laboratories
NYSE:ABT
|
US | |
Chevron Corp
NYSE:CVX
|
US | |
Occidental Petroleum Corp
NYSE:OXY
|
US | |
Matrix Service Co
NASDAQ:MTRX
|
US | |
Automatic Data Processing Inc
NASDAQ:ADP
|
US | |
Qualcomm Inc
NASDAQ:QCOM
|
US | |
Ambarella Inc
NASDAQ:AMBA
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
EW Price Targets Summary
Edwards Lifesciences Corp
According to Wall Street analysts, the average 1-year price target for EW is 76.62 USD with a low forecast of 63.63 USD and a high forecast of 94.5 USD.
EW Last Price Targets
Edwards Lifesciences Corp
The latest public price target was made on Oct 30, 2024 by David Roman from Goldman Sachs , who expects EW stock to rise by 14% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.
Operating Income
Forecast
Operating Income Estimate
Edwards Lifesciences Corp
For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's operating income is 13%. The projected CAGR for the next 3 years is 6%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is EW's stock price target?
Price Target
76.62
USD
According to Wall Street analysts, the average 1-year price target for EW is 76.62 USD with a low forecast of 63.63 USD and a high forecast of 94.5 USD.
What is Edwards Lifesciences Corp's Revenue forecast?
Projected CAGR
4%
For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's revenue is 12%. The projected CAGR for the next 3 years is 4%.
What is Edwards Lifesciences Corp's Operating Income forecast?
Projected CAGR
6%
For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's operating income is 13%. The projected CAGR for the next 3 years is 6%.
What is Edwards Lifesciences Corp's Net Income forecast?
Projected CAGR
7%
For the last 8 years the compound annual growth rate for Edwards Lifesciences Corp's net income is 14%. The projected CAGR for the next 3 years is 7%.